Fundz

Bit.bio Appoints Sejla Salic-Hainzl as Chief Technology Officer

PRIVATEAug 13, 2026

Position

Chief Technology Officer

Company

bit.bio

Sejla Salic-Hainzl
CambridgeshireInformation TechnologyFinancial ServicesSoftwareScience And EngineeringPayments

Description

bit.bio has appointed Sejla Salic-Hainzl as its first Chief Technology Officer as part of a strategic expansion of its leadership team. The new role will support the launch of ioScreen, a service aimed at enhancing drug discovery through advanced CRISPR screening technologies.

Quick answer

Bit.bio Appoints Sejla Salic-Hainzl as Chief Technology Officer (August 13, 2026). bit.bio is based in Cambridgeshire, England, United Kingdom.

Who is the new Chief Technology Officer at bit.bio?
bit.bio named Sejla Salic-Hainzl Chief Technology Officer, announced August 13, 2026.
What did bit.bio announce on August 13, 2026?
bit.bio has appointed Sejla Salic-Hainzl as its first Chief Technology Officer as part of a strategic expansion of its leadership team. The new role will support the launch of ioScreen, a service aimed at enhancing drug discovery through advanced CRISPR screening technologies.
What does bit.bio do?
bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures.
Where is bit.bio based?
bit.bio is based in Cambridgeshire, England, United Kingdom.
Which similar companies made leadership changes around the same time?
AllPaid (August 13, 2026), KuCoin (August 11, 2026), IXOPAY (August 25, 2026) and Kurv (July 22, 2026) also announced leadership changes within 45 days of bit.bio.

Source: Fundz verified event record.

Other recent leadership changes in Financial Services and Science And Engineering

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at bit.bio, and when

A new leader at bit.bio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day bit.bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at bit.bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at bit.bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

bit.bio

Location

Cambridgeshire, England, United Kingdom

About

bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines. Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable research and drug discovery teams to accelerate their experimental timelines and reduce experimental variability, providing an important alternative to traditional workflows. We are also leveraging our platform to build a pipeline of txCells for cell therapies. To achieve our goals, we have assembled a team of pioneers in stem cell biology, cell programming, mathematical modelling and cell therapy. We are empirical, highly ambitious and driven by a shared vision. Collaboration is at the heart of bit.bio. Join us on our journey.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment bit.bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Abbey
Likely contact at this company
••••••••@••••••••

See Abbey's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for bit.bio's next move

Learn about Strategic plan

bit.bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.